Literature DB >> 16459312

Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance.

Zhiyong Wang1, Chao Qi, Anna Krones, Pamela Woodring, Xiaoyan Zhu, Janardan K Reddy, Ronald M Evans, Michael G Rosenfeld, Tony Hunter.   

Abstract

Several transcriptional coactivators have been implicated in modulating the transcriptional activities of nuclear hormone receptors in vitro. Potential roles of these cofactors in important physiological processes such as energy homeostasis remain unknown. We report here that a developmental arrest in interscapular brown fat and defective adaptive thermogenesis occur in mice lacking both the p160 family transcriptional coactivators SRC-1 and p/CIP due to a failure in induction of selective PPARgamma target genes involved in adipogenesis and mitochondrial uncoupling. In the absence of p/CIP and SRC-1, mice eat more food on both regular chow and a high-fat diet because of decreased blood leptin levels. However, the p/CIP(-/-)/SRC-1(-/-) mice are lean and resistant to high-fat-diet-induced obesity. They exhibit increased basal metabolic rates and heightened levels of physical activity. Therefore, p/CIP and SRC-1 play critical roles in energy balance by controlling both energy intake and energy expenditure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16459312     DOI: 10.1016/j.cmet.2006.01.002

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  48 in total

1.  White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function.

Authors:  Youn Wook Chung; Faiyaz Ahmad; Yan Tang; Steven C Hockman; Hyun Jung Kee; Karin Berger; Emilia Guirguis; Young Hun Choi; Dan M Schimel; Angel M Aponte; Sunhee Park; Eva Degerman; Vincent C Manganiello
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 2.  Minireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?

Authors:  David M Lonard; Rakesh Kumar; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2009-10-21

Review 3.  Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism.

Authors:  David A Rollins; Maddalena Coppo; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2015-02-03

Review 4.  The epigenome and its role in diabetes.

Authors:  Hironori Waki; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

Review 5.  Regulatory circuits controlling white versus brown adipocyte differentiation.

Authors:  Jacob B Hansen; Karsten Kristiansen
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

Review 6.  Nuclear receptor coactivators: master regulators of human health and disease.

Authors:  Subhamoy Dasgupta; David M Lonard; Bert W O'Malley
Journal:  Annu Rev Med       Date:  2013-09-16       Impact factor: 13.739

7.  The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}.

Authors:  Agnès Coste; Jean-Francois Louet; Marie Lagouge; Carles Lerin; Maria Cristina Antal; Hamid Meziane; Kristina Schoonjans; Pere Puigserver; Bert W O'Malley; Johan Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

Review 8.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

9.  PRIC295, a Nuclear Receptor Coactivator, Identified from PPARα-Interacting Cofactor Complex.

Authors:  Sean R Pyper; Navin Viswakarma; Yuzhi Jia; Yi-Jun Zhu; Joseph D Fondell; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-09-05       Impact factor: 4.964

10.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.